Viewing nowCombinationIstarplus Tablets 40/5/10 mg (Telmisartan, Amlodipine, Rosuvastatin)
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
IntroBioPharma Co., Ltd.

MFDS item code 202500327 · Approved 2025.02.14
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This medication is used for patients with essential hypertension whose blood pressure is not properly controlled even after administration of a combination of telmisartan and amlodipine. Additionally, it contains rosuvastatin calcium, which helps lower blood cholesterol levels as a dietary supplement for patients with hypercholesterolemia and dyslipidemia. It is particularly effective for various lipid disorders such as homozygous familial hypercholesterolemia and dysbetalipoproteinemia. Furthermore, this medication reduces the risk of cardiovascular diseases and contributes to decreasing the risk of stroke, myocardial infarction, and recurrence after vascular revascularization. Therefore, it is a very useful treatment for patients who need to manage both blood pressure and blood lipids simultaneously.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. Patients taking a telmisartan/amlodipine combination and rosuvastatin as separate products may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this drug 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving rosuvastatin should follow a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of a 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of a 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication should not be administered during pregnancy. If pregnancy is confirmed, discontinue use immediately, as it can cause serious harm to the fetus and newborn. Patients with allergies to any ingredients in this medication or similar drugs should not take it. This medication is contraindicated in patients with severely impaired liver or kidney function, and in those with certain vascular diseases or muscle diseases. Elderly patients, patients with low blood pressure, and those with high blood potassium levels need to be careful when using this medication and regular health status checks are recommended. If symptoms such as muscle pain or weakness occur, consult a doctor immediately, and if necessary, blood tests should be performed to check for muscle damage. This medication may affect liver function, so it is advisable to undergo liver function tests before and during administration. As this medication may interact with other drugs, it is essential to inform healthcare providers about any concurrent medications being taken. This medication is not recommended for breastfeeding women, and breastfeeding should be discontinued during its use. In case of overdose, symptoms such as low blood pressure, dizziness, and renal function impairment may occur, and immediate medical assistance should be sought. When storing, keep it out of reach of children and do not transfer it to another container as a safety measure.
Viral upper respiratory tract infection, respiratory distress, anal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, oropharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, low back pain, sinusitis, diarrhea, pharyngitis, autonomic nervous system abnormalities (erectile dysfunction, increased sweating, flushing), allergies, fever, leg pain, fatigue, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, dizziness, sensory anomalies, involuntary muscle contractions, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, diabetes, arthritis, joint pain, leg numbness, anxiety, depression, nervousness, infections, fungal infections, abscess, otitis media, asthma, bronchitis, nosebleed, dermatitis, rash, eczema, pruritus, vascular edema, polymorphic eruption, thrombocytopenia, frequent urination, cystitis, increased sweating, hyperglycemia, thirst, leukopenia, purpura, headache, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremors, anorexia, dysphagia, pancreatitis, gingival hyperplasia, allergic reaction, burning sensation, fatigue, rigidity, weight gain, weight loss, sexual dysfunction, insomnia, abnormal dreams, depersonalization, vascular edema, double vision, eye pain, urination disorders, nocturia, dry mouth, edema, myalgia, myopathy, rhabdomyolysis, weakness, vascular edema, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, joint pain, fatigue, numbness, sensory anomalies, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, headache, dizziness, weakness, cough, nausea, fatigue, frailty, lower limb edema, vascular edema, pruritus, hypersensitive reactions, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, elevated blood pressure, worsened hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, urinary tract infection, erectile dysfunction, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, elevated uric acid, liver function abnormalities, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, vascular edema, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory impairment, forgetfulness, amnesia, memory disorders, confusion
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to pass through. It is important to maintain a storage temperature between 1°C and 30°C.
Pink oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
IntroBioPharma Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.